Bill C-7 will not apply to people suffering from neurodegenerative disorders such as Alzheimer’s disease, dementia, Parkinson’s disease and Huntington’s disease
BRUSSELS (Reuters) - European Commission President Ursula von der Leyen acknowledged failings on Wednesday in the EU s approval and rollout of vaccines against COVID-19, and said the bloc had learned lessons in the process. The chief of the EU executive was speaking to lawmakers in the European Parliament following criticism of the slow roll-out of vaccines and a plan to curb exports that initially sought to set up a hard border on the island of Ireland, causing an outcry in London and Dublin. Von der Leyen, who has also spoken at five groupings of EU lawmakers over the past 10 days, said 26 million vaccine doses had been delivered and that, by the end of the summer, 70% of adults in the 27-nation bloc should have been inoculated. And yet it is a fact that we are not today where we want to be in the fight against the virus, she told EU lawmakers. We were late with the approval. We were too optimistic on mass production. And perhaps we were also too certain that the orders would actuall
In its weekly epidemiological update, WHO says the variant B.1.1.7 has shown an increase in transmissibility, and some evidence of increase in disease severity based on preliminary findings.As o
Supamotion / Shutterstock.com
As Colorado expands its COVID-19 vaccine rollout, a wider variety of employers may be wondering whether they can require their employees to be inoculated against the disease. In some cases, legal experts say the answer may be yes, but there are plenty of caveats.
âCOVID-19 has been deemed a direct threat, and as a direct threat the employer would need to make some analysis as to whether or not the employee is a direct threat to either other employees or the public given the work situation to then justify the mandate for having a vaccination,â says Chris Wilhelmi, an attorney with Stinar Zendejas Burrell & Wilhelmi in Colorado Springs.